Researchers have found bariatric surgery to be more cost-effective for treating patients with obesity compared with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to new study ...

New study finds GLP-1 meds like Ozempic may make food taste sweeter or saltier. Here's how this new side effect might impact ...

Patients on Eli Lilly & Co.’s experimental diabetes pill lost more weight and had better blood sugar control than those on an ...

Eli Lilly on Wednesday said its experimental pill led to more weight loss and better control of blood sugar in patients with ...

Do natural GLP-1 alternatives work? This article was reviewed by Brian Tanzer, nutritionist and Director of Scientific and ...

Beijing QL Biopharmaceutical has shared phase 2 data on its once-monthly GLP-1 candidate, providing early evidence that the ...

GLP-1 drugs are so powerful that, in 20 years, they can save millions from premature death, a leading insurance company says.

Weight-loss medications reduced body weight in children and teens, but the sample size was too small to make conclusions ...

Delayed gastric emptying, potential aspiration risks, and medication interactions — learn the hospitalist’s approach to ...

This multicenter, prospective observational study is published in Frontiers in Clinical Diabetes and Healthcare. “Pre-treatment assessment of eating behavior patterns may help predict who will benefit ...

A new report published by the global insurance company Swiss Re sees GLP-1 drugs reducing US mortality rates by 6.4% by 2045.

The 7- and 14-mg semaglutide doses included in Lilly’s trial match those of Novo’s Rybelsus, an oral version of the GLP-1 semaglutide that is approved as a first-line treatment option in type 2 ...